UK agency gives advice on reporting stent incidents
This article was originally published in Clinica
The UK's Medical Devices Agency (MDA) has published guidance to help manufacturers of CE-marked coronary stents understand their reporting responsibilities when adverse or near incidents occur.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.